GERAX
Price
$11.34
Change
-$0.08 (-0.70%)
Updated
Nov 13 closing price
Net Assets
2.68B
VEMAX
Price
$45.50
Change
-$0.31 (-0.68%)
Updated
Nov 13 closing price
Net Assets
141.19B
Interact to see
Advertisement

GERAX vs VEMAX

Header iconGERAX vs VEMAX Comparison
Open Charts GERAX vs VEMAXBanner chart's image
Goldman Sachs Em Mkts Eq Insghts A
Price$11.34
Change-$0.08 (-0.70%)
VolumeN/A
Net Assets2.68B
Vanguard Emerging Mkts Stock Idx Adm
Price$45.50
Change-$0.31 (-0.68%)
VolumeN/A
Net Assets141.19B
GERAX vs VEMAX Comparison Chart in %
View a ticker or compare two or three
VS
GERAX vs. VEMAX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GERAX is a Buy and VEMAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 141B vs. GERAX (2.68B). VEMAX pays higher dividends than GERAX: VEMAX (2.75) vs GERAX (0.77). GERAX was incepted earlier than VEMAX: GERAX (18 years) vs VEMAX (19 years). GERAX (1.51) is less costly to investors than VEMAX (0.13). GERAX is a more actively managed with annual turnover of: 168.00 vs. VEMAX (8.00). GERAX has a lower initial minimum investment than VEMAX: GERAX (1000) vs VEMAX (3000). GERAX annual gain was more profitable for investors over the last year : 30.61 vs. VEMAX (22.65). VEMAX return over 5 years is better than : 27.91 vs. GERAX (15.12).
GERAXVEMAXGERAX / VEMAX
Total Expense Ratio1.340.131,031%
Annual Report Gross Expense Ratio1.510.131,162%
Fund Existence18 years19 years-
Gain YTD30.64524.426125%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRA250N/A-
Net Assets2.68B141B2%
Annual Yield % from dividends0.772.7528%
Returns for 1 year30.6122.65135%
Returns for 3 years61.9150.90122%
Returns for 5 years15.1227.9154%
Returns for 10 years69.2888.0579%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBTTX33.84N/A
N/A
Fidelity Advisor Biotechnology M
NMMEX19.46-0.18
-0.92%
Northern Active M Emerging Market Equity
DGOCX27.91-0.38
-1.34%
Davis Opportunity C
GEMPX14.81-0.22
-1.46%
Goldman Sachs Emerging Mkts Eq ex. Chn P
ASERX127.42-2.83
-2.17%
American Century Select R